Page last updated: 2024-10-20

pyrazinamide and Diabetes Insipidus

pyrazinamide has been researched along with Diabetes Insipidus in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holmes, EW1
Kelley, WN1
Wyngaarden, JB1
Bartsocas, CS1
Pantelakis, SN1

Reviews

1 review available for pyrazinamide and Diabetes Insipidus

ArticleYear
Editorial: The kidney and uric acid excretion in man.
    Kidney international, 1972, Volume: 2, Issue:3

    Topics: Angiotensin II; Animals; Biological Transport, Active; Blood Proteins; Diabetes Insipidus; Diet, Sod

1972

Other Studies

1 other study available for pyrazinamide and Diabetes Insipidus

ArticleYear
Human growth hormone therapy in hypopituitarism due to tuberculous meningitis.
    Acta paediatrica Scandinavica, 1973, Volume: 62, Issue:3

    Topics: Adolescent; Aminosalicylic Acids; Blood Glucose; Body Height; Calcinosis; Child; Child, Preschool; D

1973